What we do

Project Strategy

We believe that the secrets of success are careful planning, focus and not trying to do too much, too soon.   Over the next eighteen months, we are focusing on three main strands:

  1. Further development of “Bipolar In Touch“, our collaborative network with more than 3500 people affected by bipolar disorder.
  2. Implementation of a new psychoeducation program about bipolar illness in selected centres  using a model which has already been shown to be effective.
  3. Consolidation of fundraising and development infrastructure.

The Foundation’s goal is to become a worldwide network of people with bipolar disorder; unique because of its two-way partnership between those affected and clinician researchers.  The fact that the foundation will be aiming from the start to actively improve treatment,  by supporting the implementation of a psychoeducation program will, we hope, speak for itself.

The Bipolar Foundation program will carefully evaluate the biological, psychological and social factors important in bipolar disorder. In the first wave, we are examining experience and attitudes to psychological interventions as well evaluating pharmacotherapy and genetic susceptibility in relation to bipolar disorder.

We have also made our first two research awards – one looks at the genetic factors operating in bipolar disorder (based at University College,  London), the other is concerned with new talking therapies for bipolar disorder (at Oxford University).  We feel that these two very different projects offer a ‘balance’ in our desire to seek new paths forward.  It is one of our key aims to interest people in participating in the work of these different areas – as part of a long term partnership.

A pragmatic business plan

We want to fund projects and programs that make a difference to people.  The plan for the next five years of development of the Foundation’s program is balanced between ensuring a base of solid and sustainable infrastructure support for ongoing education, outreach, research and clinical excellence, coupled with the promotion of programs and funding for the component projects of these programs themselves. A first rate plan of fundraising and associated corporate partnerships (with links to research and care) is key to this.